This page is part of the FHIR Specification v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw Turtle (+ also see Turtle/RDF Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Alemtuzumab - completed with multiple dosageInstruction lines
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix sct: <http://snomed.info/id/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- [a fhir:MedicationRequest ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "medrx0317"] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"medrx0317\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest "medrx0317" </p></div><p><b>identifier</b>: id: 12345689 (use: OFFICIAL)</p><p><b>status</b>: completed</p><p><b>intent</b>: order</p><h3>Medications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a name=\"med0303\"> </a><blockquote><p/><p><a name=\"med0303\"> </a></p><p><b>code</b>: alemtuzumab 10 MG/ML [Lemtrada] <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.4.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#1594660)</span></p></blockquote></td></tr></table><p><b>subject</b>: <a href=\"patient-example-a.html\">Patient/pat1: Donald Duck</a> "Donald DUCK"</p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a href=\"practitioner-example-f007-sh.html\">Practitioner/f007: Patrick Pump</a> "Simone HEPS"</p><h3>Reasons</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Chronic Lymphoid Leukemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#92814006)</span></td></tr></table><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstruction</b>: Rapidly increase dose until tolerated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span>, Administer on alternate days <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>timing</b>: Duration 12weeks, 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 2</p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstruction</b>: Rapidly increase dose until tolerated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span>, Administer on alternate days <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>timing</b>: Duration 12weeks, 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 3</p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstruction</b>: Rapidly increase dose until tolerated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span>, Administer on alternate days <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>timing</b>: Duration 12weeks, 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>" ] ; # fhir:contained ( [ a fhir:Medication ; fhir:id [ fhir:v "med0303" ] ; fhir:code [ fhir:coding ( [ fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ; fhir:code [ fhir:v "1594660" ] ; fhir:display [ fhir:v "alemtuzumab 10 MG/ML [Lemtrada]" ] ] ) ] ] ) ; # fhir:identifier ( [ fhir:use [ fhir:v "official" ] ; fhir:system [ fhir:v "http://www.bmc.nl/portal/prescriptions"^^xsd:anyURI ] ; fhir:value [ fhir:v "12345689" ] ] ) ; # fhir:status [ fhir:v "completed"] ; # fhir:intent [ fhir:v "order"] ; # fhir:medication [ fhir:reference [ fhir:reference [ fhir:v "#med0303" ] ] ] ; # fhir:subject [ fhir:reference [ fhir:v "Patient/pat1" ] ; # Linked to the resource patient who needs the medication fhir:display [ fhir:v "Donald Duck" ] ] ; # fhir:authoredOn [ fhir:v "2015-01-15"^^xsd:date] ; # fhir:requester [ fhir:reference [ fhir:v "Practitioner/f007" ] ; fhir:display [ fhir:v "Patrick Pump" ] ] ; # fhir:reason ( [ fhir:concept [ fhir:coding ( [ a sct:92814006 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "92814006" ] ; fhir:display [ fhir:v "Chronic Lymphoid Leukemia (disorder)" ] ] ) ] ] ) ; # fhir:dosageInstruction ( [ fhir:sequence [ fhir:v "1"^^xsd:integer ] ; fhir:text [ fhir:v "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk" ] ; fhir:additionalInstruction ( [ fhir:text [ fhir:v "Rapidly increase dose until tolerated" ] ] [ fhir:text [ fhir:v "Administer on alternate days" ] ] ) ; fhir:timing [ fhir:repeat [ fhir:duration [ fhir:v "12"^^xsd:decimal ] ; fhir:durationUnit [ fhir:v "wk" ] ; fhir:frequency [ fhir:v "3"^^xsd:positiveInteger ] ; fhir:period [ fhir:v "1"^^xsd:decimal ] ; fhir:periodUnit [ fhir:v "wk" ] ] ] ; fhir:route [ fhir:coding ( [ a sct:47625008 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "47625008" ] ; fhir:display [ fhir:v "Intravenous route (qualifier value)" ] ] ) ] ; fhir:method [ fhir:coding ( [ a sct:422145002 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "422145002" ] ; fhir:display [ fhir:v "Inject - dosing instruction imperative (qualifier value)" ] ] ) ] ; fhir:doseAndRate ( [ fhir:type [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/dose-rate-type"^^xsd:anyURI ] ; fhir:code [ fhir:v "ordered" ] ; fhir:display [ fhir:v "Ordered" ] ] ) ] ; fhir:dose [ a fhir:Quantity ; fhir:value [ fhir:v "3"^^xsd:decimal ] ; fhir:unit [ fhir:v "mg" ] ; fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ; fhir:code [ fhir:v "mg" ] ] ] ) ] [ fhir:sequence [ fhir:v "2"^^xsd:integer ] ; fhir:text [ fhir:v "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk" ] ; fhir:additionalInstruction ( [ fhir:text [ fhir:v "Rapidly increase dose until tolerated" ] ] [ fhir:text [ fhir:v "Administer on alternate days" ] ] ) ; fhir:timing [ fhir:repeat [ fhir:duration [ fhir:v "12"^^xsd:decimal ] ; fhir:durationUnit [ fhir:v "wk" ] ; fhir:frequency [ fhir:v "3"^^xsd:positiveInteger ] ; fhir:period [ fhir:v "1"^^xsd:decimal ] ; fhir:periodUnit [ fhir:v "wk" ] ] ] ; fhir:route [ fhir:coding ( [ a sct:47625008 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "47625008" ] ; fhir:display [ fhir:v "Intravenous route (qualifier value)" ] ] ) ] ; fhir:method [ fhir:coding ( [ a sct:422145002 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "422145002" ] ; fhir:display [ fhir:v "Inject - dosing instruction imperative (qualifier value)" ] ] ) ] ; fhir:doseAndRate ( [ fhir:type [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/dose-rate-type"^^xsd:anyURI ] ; fhir:code [ fhir:v "ordered" ] ; fhir:display [ fhir:v "Ordered" ] ] ) ] ; fhir:dose [ a fhir:Quantity ; fhir:value [ fhir:v "10"^^xsd:decimal ] ; fhir:unit [ fhir:v "mg" ] ; fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ; fhir:code [ fhir:v "mg" ] ] ] ) ] [ fhir:sequence [ fhir:v "3"^^xsd:integer ] ; fhir:text [ fhir:v "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk" ] ; fhir:additionalInstruction ( [ fhir:text [ fhir:v "Rapidly increase dose until tolerated" ] ] [ fhir:text [ fhir:v "Administer on alternate days" ] ] ) ; fhir:timing [ fhir:repeat [ fhir:duration [ fhir:v "12"^^xsd:decimal ] ; fhir:durationUnit [ fhir:v "wk" ] ; fhir:frequency [ fhir:v "3"^^xsd:positiveInteger ] ; fhir:period [ fhir:v "1"^^xsd:decimal ] ; fhir:periodUnit [ fhir:v "wk" ] ] ] ; fhir:route [ fhir:coding ( [ a sct:47625008 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "47625008" ] ; fhir:display [ fhir:v "Intravenous route (qualifier value)" ] ] ) ] ; fhir:method [ fhir:coding ( [ a sct:422145002 ; fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ; fhir:code [ fhir:v "422145002" ] ; fhir:display [ fhir:v "Inject - dosing instruction imperative (qualifier value)" ] ] ) ] ; fhir:doseAndRate ( [ fhir:type [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/dose-rate-type"^^xsd:anyURI ] ; fhir:code [ fhir:v "ordered" ] ; fhir:display [ fhir:v "Ordered" ] ] ) ] ; fhir:dose [ a fhir:Quantity ; fhir:value [ fhir:v "30"^^xsd:decimal ] ; fhir:unit [ fhir:v "mg" ] ; fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ; fhir:code [ fhir:v "mg" ] ] ] ) ] )] . # # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.core#6.0.0-ballot1 generated on Mon, Dec 18, 2023 15:17+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R5 |
|
Propose a change